Clinical Trials Browser

Pancreatic Intraductal Neoplasms × Immunohistochemistry × Gastrointestinal × Clear all

NCT00482625 2014-10-16

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2 Terminated

6 enrolled 8 charts

Gastrointestinal

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms